Scientists have conducted breakthrough research that could lead to a universal cancer vaccine, revolutionizing how the disease is treated.

A vaccine that uses lipid nanoparticles to deliver allergen-specific messenger RNA (mRNA) showed early positive results at managing severe allergies in tests involving mice, according to a study led ...

To solve a problem, scientists first need to see it clearly. Whether it’s a virus slipping past the immune system or plaques ...

People are still debating whether the mRNA from COVID-19 vaccines remains in the body longer than it should. Some say it ...

mRNA Vaccines dominated the market in 2024, accounting for over US$ 36 billion in revenues. Pfizer, Moderna, and BioNTech ...

Arcturus Therapeutics is transitioning from COVID-era revenues to milestone-driven growth. Click here to read more on ARCT ...

Russia’s FMBA reports early success of Enteromix, a personalised mRNA cancer vaccine. Promising but untested in India, ...

STONY BROOK, NY / ACCESS Newswire / September 23, 2025 /Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the ...

Moderna said on Tuesday its updated COVID-19 vaccine formulation elicited a strong immune response in all adults aged 65 and ...

An Australian research team has achieved an advanced materials breakthrough that opens the door to a new generation of nanodrug applications. From drug delivery, to diagnostics, to gene editing and ...

This article explores innovative drug delivery strategies, including DNA barcoding, shape-engineered nanoparticles and ...

Biotech company Arcturus Therapeutics sued AbbVie in California federal court on Tuesday for allegedly stealing trade secrets related to its drug-delivery technology.